Objective: To study the sexuality of pregnant women after Assisted Reproductive Technology (ART).
Methods: This was a prospective multicenter study based on two questionnaires: the Female Sexual Function Index (FSFI) and the Couple Satisfaction Index 32 (CSI 32). Two groups were compared: pregnancies following ART and spontaneous pregnancies.
Results: A total of 401 women participated: 215 in the ART group and 186 in the spontaneous pregnancy group. Sexual dysfunction was observed in 49.8% of women in the ART group (n=108/215) and 44.1% in the spontaneous pregnancy group (n=82/186). The FSFI score was not significantly lower in the second trimester (24.0 ± 9.3 for ART vs 25.9 ± 7.3 for spontaneous pregnancy, p=0.07) but was significantly reduced across all trimesters (23.4 ± 9.2 vs 25.4 ± 5.8, p=0.02). Couple relationship quality (CSI 32) was similar between the two groups (134.4 ± 22.2 vs 133.9 ± 23.9, p=0.85). Only 13.9% of ART women (n=30/215) and 8.6% of spontaneous pregnancy women (n=16/186) had discussed their sexuality during pregnancy with a healthcare professional.
Conclusion: The prevalence of sexual dysfunction during pregnancy is high, particularly among women followed for ART. However, the quality of the couple's relationship remains comparable between the two groups.
{"title":"[Sexuality of the couple during pregnancy after assisted reproductive technology: a comparative study.]","authors":"Marine Beaumont, Mikael Agopiantz, Jeannine Ohl, Marie-Laure Eszto, Cedric Baumann, Matthieu Dap","doi":"10.1016/j.gofs.2025.01.005","DOIUrl":"https://doi.org/10.1016/j.gofs.2025.01.005","url":null,"abstract":"<p><strong>Objective: </strong>To study the sexuality of pregnant women after Assisted Reproductive Technology (ART).</p><p><strong>Methods: </strong>This was a prospective multicenter study based on two questionnaires: the Female Sexual Function Index (FSFI) and the Couple Satisfaction Index 32 (CSI 32). Two groups were compared: pregnancies following ART and spontaneous pregnancies.</p><p><strong>Results: </strong>A total of 401 women participated: 215 in the ART group and 186 in the spontaneous pregnancy group. Sexual dysfunction was observed in 49.8% of women in the ART group (n=108/215) and 44.1% in the spontaneous pregnancy group (n=82/186). The FSFI score was not significantly lower in the second trimester (24.0 ± 9.3 for ART vs 25.9 ± 7.3 for spontaneous pregnancy, p=0.07) but was significantly reduced across all trimesters (23.4 ± 9.2 vs 25.4 ± 5.8, p=0.02). Couple relationship quality (CSI 32) was similar between the two groups (134.4 ± 22.2 vs 133.9 ± 23.9, p=0.85). Only 13.9% of ART women (n=30/215) and 8.6% of spontaneous pregnancy women (n=16/186) had discussed their sexuality during pregnancy with a healthcare professional.</p><p><strong>Conclusion: </strong>The prevalence of sexual dysfunction during pregnancy is high, particularly among women followed for ART. However, the quality of the couple's relationship remains comparable between the two groups.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143043465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-23DOI: 10.1016/j.gofs.2025.01.004
Laëtitia Saccenti, Thu Ha Dao, Vania Tacher
{"title":"[The role of mammography in prevention of cardiovascular risk in women].","authors":"Laëtitia Saccenti, Thu Ha Dao, Vania Tacher","doi":"10.1016/j.gofs.2025.01.004","DOIUrl":"https://doi.org/10.1016/j.gofs.2025.01.004","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143043467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-16DOI: 10.1016/j.gofs.2025.01.003
Mikaël Agopiantz, Thomas Fréour, Lisa Neumann, Maxime Chaillot, Olivier Morel
{"title":"[Reception of oocytes from partner (ROPA) in France: context and perspectives].","authors":"Mikaël Agopiantz, Thomas Fréour, Lisa Neumann, Maxime Chaillot, Olivier Morel","doi":"10.1016/j.gofs.2025.01.003","DOIUrl":"https://doi.org/10.1016/j.gofs.2025.01.003","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Fear of pain during intrauterine device (IUD) insertion remains a barrier to its adoption. In the absence of consensus on an optimal pharmacological strategy, it is crucial to determine the factors influencing this pain to reassure and improve the patient experience.
Methods: It was a prospective study conducted in Provence-Alpes-Côte d'Azur between August 2023 and 2024, interviewing adult patients and healthcare professionals during consultations for IUD insertion. The primary outcome studied was the pain experienced during IUD insertion, measured using a numerical rating scale from 0 to 10. After an univariate analysis, a multiple linear regression was performed to identify the factors associated with this pain.
Results: Of the 110 questionnaires analyzed, the average pain score at IUD insertion was 4.1±2.7. Factors associated with pain included European origin, no history of vaginal delivery, apprehension and use of a tenaculum. In contrast, prior IUD insertion, the presence of dysmenorrhea, menstruation at the time of insertion, or premedication had no significant effect on pain. Prior bladder emptying and the use of equimolar mixture of oxygene and nitrous oxide (EMONO) could also be considered as strategies but require further studies.
Conclusion: IUD insertion should be played down, given the moderate and temporary pain it causes. Physicians have a key role in identifying patients at risk of increased pain in order to provide them a personalized approach.
{"title":"[Factors influencing pain during intrauterine device insertion].","authors":"Chloé Guerry, Hélène Piclet, Florence Bretelle, Julien Mancini, Aubert Agostini, Mallaury Vitabile","doi":"10.1016/j.gofs.2024.12.007","DOIUrl":"10.1016/j.gofs.2024.12.007","url":null,"abstract":"<p><strong>Objectives: </strong>Fear of pain during intrauterine device (IUD) insertion remains a barrier to its adoption. In the absence of consensus on an optimal pharmacological strategy, it is crucial to determine the factors influencing this pain to reassure and improve the patient experience.</p><p><strong>Methods: </strong>It was a prospective study conducted in Provence-Alpes-Côte d'Azur between August 2023 and 2024, interviewing adult patients and healthcare professionals during consultations for IUD insertion. The primary outcome studied was the pain experienced during IUD insertion, measured using a numerical rating scale from 0 to 10. After an univariate analysis, a multiple linear regression was performed to identify the factors associated with this pain.</p><p><strong>Results: </strong>Of the 110 questionnaires analyzed, the average pain score at IUD insertion was 4.1±2.7. Factors associated with pain included European origin, no history of vaginal delivery, apprehension and use of a tenaculum. In contrast, prior IUD insertion, the presence of dysmenorrhea, menstruation at the time of insertion, or premedication had no significant effect on pain. Prior bladder emptying and the use of equimolar mixture of oxygene and nitrous oxide (EMONO) could also be considered as strategies but require further studies.</p><p><strong>Conclusion: </strong>IUD insertion should be played down, given the moderate and temporary pain it causes. Physicians have a key role in identifying patients at risk of increased pain in order to provide them a personalized approach.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-11DOI: 10.1016/j.gofs.2025.01.001
Caroline Charlier, Olivia Anselem, Marion Caseris, Marie Lachâtre, Asmaa Tazi, Marine Driessen, Didier Pinquier, Chemsa Le Cœur, Aurélie Saunier, Mathilde Bergamelli, Roxane Gibert Vanspranghels, Anaïs Chosidow, Charles Cazanave, Sophie Alain, Karine Faure, André Birgy, François Dubos, Philippe Lesprit, Julie Guinaud, Robert Cohen, Jean-Winoc Decousser, Emmanuel Grimprel, Cyril Huissoud, Julie Blanc, Gilles Kayem, Fanny Vuotto, Christelle Vauloup-Fellous
The Société de Pathologie Infectieuse de Langue Française released in 2024 a new national recommendation for clinical practice on the prevention and management of varicella zoster virus (VZV) infection during pregnancy and the perinatal period. The previous recommendation was issued in 1998, at a time of anti-VZV immunoglobulins shortage; it has hence become obsolete. This recommendation is a formalized expert consensus focusing on infectious diseases management; it is drawn up by a multidisciplinary working group (infectiologists, obstetricians, pediatricians, microbiologists, midwives, hygienists). It has been endorsed by the Collège National des Gynécologues Obstétriciens Français, the Société Française de Médecine Périnatale, the Société Française de Néonatologie, the Collège des Sage-femmes, and the Groupe Infections et Périnatalité of the Société Française de Microbiologie. The aim of this article is to explain and recontextualize the elements of this recommendation.
{"title":"[Recommendations for clinical practice: Prevention and management of varicella zoster virus (VZV) infection during pregnancy and the perinatal period (extended version)].","authors":"Caroline Charlier, Olivia Anselem, Marion Caseris, Marie Lachâtre, Asmaa Tazi, Marine Driessen, Didier Pinquier, Chemsa Le Cœur, Aurélie Saunier, Mathilde Bergamelli, Roxane Gibert Vanspranghels, Anaïs Chosidow, Charles Cazanave, Sophie Alain, Karine Faure, André Birgy, François Dubos, Philippe Lesprit, Julie Guinaud, Robert Cohen, Jean-Winoc Decousser, Emmanuel Grimprel, Cyril Huissoud, Julie Blanc, Gilles Kayem, Fanny Vuotto, Christelle Vauloup-Fellous","doi":"10.1016/j.gofs.2025.01.001","DOIUrl":"https://doi.org/10.1016/j.gofs.2025.01.001","url":null,"abstract":"<p><p>The Société de Pathologie Infectieuse de Langue Française released in 2024 a new national recommendation for clinical practice on the prevention and management of varicella zoster virus (VZV) infection during pregnancy and the perinatal period. The previous recommendation was issued in 1998, at a time of anti-VZV immunoglobulins shortage; it has hence become obsolete. This recommendation is a formalized expert consensus focusing on infectious diseases management; it is drawn up by a multidisciplinary working group (infectiologists, obstetricians, pediatricians, microbiologists, midwives, hygienists). It has been endorsed by the Collège National des Gynécologues Obstétriciens Français, the Société Française de Médecine Périnatale, the Société Française de Néonatologie, the Collège des Sage-femmes, and the Groupe Infections et Périnatalité of the Société Française de Microbiologie. The aim of this article is to explain and recontextualize the elements of this recommendation.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142980654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-10DOI: 10.1016/j.gofs.2025.01.002
Erdogan Nohuz, Philippe Chabert, Gautier Chene
{"title":"[How do I do… Clitoral reconstructive surgery after ritual excision in ten steps].","authors":"Erdogan Nohuz, Philippe Chabert, Gautier Chene","doi":"10.1016/j.gofs.2025.01.002","DOIUrl":"10.1016/j.gofs.2025.01.002","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-08DOI: 10.1016/j.gofs.2024.12.006
Ornella Maltese, Pierre Macé, Alice Faure, Rachel Reynaud, Jean Philippe Bault, Guillaume Gorincour, Edwin Quarello
The management of a fetus suspected of having a variation in genital development is a complex situation. In cases of complete discordance or an unusual appearance of the external genitalia (EG), management always begins with a diagnostic morphological ultrasound. This ultrasound aims to provide detailed imaging of the EG and internal genitalia (IG), focusing on identifying the presence of Müllerian derivatives and detecting any associated malformations. During a multidisciplinary meeting, we should assess the appropriateness of determining the genetic sex through cell-free DNA analysis and to refer the patient to an expert center if necessary.These clinical situations include all atypical presentations of the genital organs with the inability to determine the phenotype, as well as any hypospadias associated with other genital organ involvement. Patients presenting with isolated posterior (or proximal) hypospadias also benefit from an assessment at an expert center. Isolated anterior and middle hypospadias (with negative genetic findings) are excluded from this protocol. Performing an invasive sampling is almost always indicated. The expert center provides the couple with information on the different variations of genital development and the perspectives of managing the child, explaining the recently proposed paradigm shift, according to the new decree of November 15, 2022, in application of Article L-2131-6 of the Public Health Code, which now entails, in some of these situations, delayed surgical management. The diagnostic and prognostic uncertainty of the developmental variation is communicated to the couples. Multidisciplinary care is therefore essential to establish an accurate diagnosis, define the anatomical and functional prognosis, and propose the most appropriate surgical strategy, taking into account the associated morbidities, defining whether or not to adopt a surgical strategy, and providing the most suitable surgical approach, as well as supporting the couple and the child in dealing with this situation.
{"title":"[Management of a fetus suspected of differences of sex development (DSD).]","authors":"Ornella Maltese, Pierre Macé, Alice Faure, Rachel Reynaud, Jean Philippe Bault, Guillaume Gorincour, Edwin Quarello","doi":"10.1016/j.gofs.2024.12.006","DOIUrl":"https://doi.org/10.1016/j.gofs.2024.12.006","url":null,"abstract":"<p><p>The management of a fetus suspected of having a variation in genital development is a complex situation. In cases of complete discordance or an unusual appearance of the external genitalia (EG), management always begins with a diagnostic morphological ultrasound. This ultrasound aims to provide detailed imaging of the EG and internal genitalia (IG), focusing on identifying the presence of Müllerian derivatives and detecting any associated malformations. During a multidisciplinary meeting, we should assess the appropriateness of determining the genetic sex through cell-free DNA analysis and to refer the patient to an expert center if necessary.These clinical situations include all atypical presentations of the genital organs with the inability to determine the phenotype, as well as any hypospadias associated with other genital organ involvement. Patients presenting with isolated posterior (or proximal) hypospadias also benefit from an assessment at an expert center. Isolated anterior and middle hypospadias (with negative genetic findings) are excluded from this protocol. Performing an invasive sampling is almost always indicated. The expert center provides the couple with information on the different variations of genital development and the perspectives of managing the child, explaining the recently proposed paradigm shift, according to the new decree of November 15, 2022, in application of Article L-2131-6 of the Public Health Code, which now entails, in some of these situations, delayed surgical management. The diagnostic and prognostic uncertainty of the developmental variation is communicated to the couples. Multidisciplinary care is therefore essential to establish an accurate diagnosis, define the anatomical and functional prognosis, and propose the most appropriate surgical strategy, taking into account the associated morbidities, defining whether or not to adopt a surgical strategy, and providing the most suitable surgical approach, as well as supporting the couple and the child in dealing with this situation.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142967464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-31DOI: 10.1016/j.gofs.2024.12.005
Clémence Cirade, Inès Braham, Jérôme Delotte, Samir Boukaidi, Sarah Dupuis, Adeline Morisot, Valérie Benoit, Nicolas Chevalier
Objectives: The Bioethics Law of August 2nd, 2021 established access to origins for people conceived by gamete donation. Two years after the implementation of this disposition, what is the proportion of former gamete donors informed about access to origins, and what is their position on this matter? What could be the potential repercussions of this new law on them?
Methods: Retrospective single-center cohort study using questionnaires.
Results: When former gamete donors were asked about access to origins, only 53% of oocytes donors and 71% of sperm donors were aware of this measure. When participants were asked about the ideal method of donation, it emerged that 41% of female donors and 47% of male donors were in favour of access to their identifying data for the person resulting from the donation. More than half were in favour of access to non-identifying and medical data. If one day someone conceived from their donation requested access to their identifying data, 62% of oocytes donors and 56% of sperm donors would grant it.
Conclusions: A significant proportion of our participants expressed the desire to benefit from information on possible descendants resulting from their donation. Among the donors interviewed, only half are informed of the legislation introducing access to origins, now two years after its implementation. These results encourage us to strengthen communication efforts around access to origins.
{"title":"[Visions and repercussions of identity-release in oocyte and sperm donors: Descriptive survey among gamete donors].","authors":"Clémence Cirade, Inès Braham, Jérôme Delotte, Samir Boukaidi, Sarah Dupuis, Adeline Morisot, Valérie Benoit, Nicolas Chevalier","doi":"10.1016/j.gofs.2024.12.005","DOIUrl":"10.1016/j.gofs.2024.12.005","url":null,"abstract":"<p><strong>Objectives: </strong>The Bioethics Law of August 2nd, 2021 established access to origins for people conceived by gamete donation. Two years after the implementation of this disposition, what is the proportion of former gamete donors informed about access to origins, and what is their position on this matter? What could be the potential repercussions of this new law on them?</p><p><strong>Methods: </strong>Retrospective single-center cohort study using questionnaires.</p><p><strong>Results: </strong>When former gamete donors were asked about access to origins, only 53% of oocytes donors and 71% of sperm donors were aware of this measure. When participants were asked about the ideal method of donation, it emerged that 41% of female donors and 47% of male donors were in favour of access to their identifying data for the person resulting from the donation. More than half were in favour of access to non-identifying and medical data. If one day someone conceived from their donation requested access to their identifying data, 62% of oocytes donors and 56% of sperm donors would grant it.</p><p><strong>Conclusions: </strong>A significant proportion of our participants expressed the desire to benefit from information on possible descendants resulting from their donation. Among the donors interviewed, only half are informed of the legislation introducing access to origins, now two years after its implementation. These results encourage us to strengthen communication efforts around access to origins.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-21DOI: 10.1016/j.gofs.2024.12.003
Elie Mouanes-Abelin, Sophie Brouillet, Fatima Barry, Margaux Anav, Alice Fournier, Anéta Andreeva, Marine Miaille, Tal Anahory, Samir Hamamah
It is now widely recognized that, following prolonged culture, the transfer of a high-quality morphologically graded blastocyst is the preferred strategy in embryo transfer. Low-grade blastocysts are often considered to have a low implantation potential, and their use remains highly limited. We conducted a general review of the literature, including publications from August 2017 to October 2023, to assess the current state of knowledge regarding these embryos, which are generally excluded in routine practice. Our primary outcome measure was the "live birth rate" following the frozen transfer of a low-grade morphologically classified blastocyst according to the Gardner classification. The "miscarriage rates" were also evaluated. The bibliographic research led to the selection of 9 articles. Low-grade blastocysts can result in live births, with rates ranging from 5.97 to 40%, and in the birth of healthy children, which remains the primary goal of assisted reproductive technology. It would therefore be relevant to reconsider the routine use of these embryos.
{"title":"[Increasing the cumulative live birth rate: Low-grade blastocysts, potential overlook].","authors":"Elie Mouanes-Abelin, Sophie Brouillet, Fatima Barry, Margaux Anav, Alice Fournier, Anéta Andreeva, Marine Miaille, Tal Anahory, Samir Hamamah","doi":"10.1016/j.gofs.2024.12.003","DOIUrl":"10.1016/j.gofs.2024.12.003","url":null,"abstract":"<p><p>It is now widely recognized that, following prolonged culture, the transfer of a high-quality morphologically graded blastocyst is the preferred strategy in embryo transfer. Low-grade blastocysts are often considered to have a low implantation potential, and their use remains highly limited. We conducted a general review of the literature, including publications from August 2017 to October 2023, to assess the current state of knowledge regarding these embryos, which are generally excluded in routine practice. Our primary outcome measure was the \"live birth rate\" following the frozen transfer of a low-grade morphologically classified blastocyst according to the Gardner classification. The \"miscarriage rates\" were also evaluated. The bibliographic research led to the selection of 9 articles. Low-grade blastocysts can result in live births, with rates ranging from 5.97 to 40%, and in the birth of healthy children, which remains the primary goal of assisted reproductive technology. It would therefore be relevant to reconsider the routine use of these embryos.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.gofs.2024.12.002
Anais Malandain, Mathilde Barrois
Objective: This study aims to identify factors associated with depressive and anxious symptomatology in pregnant women hospitalized during the antepartum period in home care management (Hospitalisation à domicile).
Method: This is a quantitative, single-center, observational, and descriptive study that included all French-speaking women hospitalized in the HAD of AP-HP between September 2022 and February 2023. Anxious and depressive symptoms were assessed using the self-administered HADS (Hospital Anxiety and Depression Scale) questionnaire. Analyses were conducted according to two distinct groups, comparing patients with an anxiety or depression scores below 8 on the HADS to those with a score of 8 or above (the threshold set on the questionnaire corresponding to intermediate symptomatology). A second questionnaire created for the study detailed maternal history, pregnancy experience, and lifestyle.
Results: A total of sixty-four women were included from September 20, 2022, to February 15, 2023. Eighteen women (28%) evaluated had anxious symptomatology and thirteen women (20%) had depressive symptomatology. Factors significantly associated with anxiety were poor pregnancy experience (P=0.04), the need for psychological follow-up during pregnancy (P<0.01), country of birth (P=0.022), as well as psychiatric history such as previous consultations with a mental health specialist (P=0.015) and previous psychotropic treatment (P=0.028). Additionally, a history of violence (respectively, P=0.034 and P<0.01) and the women's belief that a consultation with a psychologist would benefit them were also associated with anxious and depressive symptomatology (respectively, P<0.01 and P<0.01) CONCLUSION: Our results highlight the importance and necessity of enhancing the screening and prevention of various mental disorders during pregnancy. It would be interesting to implement organized screening for anxiety, similar to depression, in pregnant women hospitalized at home and for the entire obstetric population.
{"title":"[Assesment of anxiety and depression in pregnant women in home care management].","authors":"Anais Malandain, Mathilde Barrois","doi":"10.1016/j.gofs.2024.12.002","DOIUrl":"10.1016/j.gofs.2024.12.002","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to identify factors associated with depressive and anxious symptomatology in pregnant women hospitalized during the antepartum period in home care management (Hospitalisation à domicile).</p><p><strong>Method: </strong>This is a quantitative, single-center, observational, and descriptive study that included all French-speaking women hospitalized in the HAD of AP-HP between September 2022 and February 2023. Anxious and depressive symptoms were assessed using the self-administered HADS (Hospital Anxiety and Depression Scale) questionnaire. Analyses were conducted according to two distinct groups, comparing patients with an anxiety or depression scores below 8 on the HADS to those with a score of 8 or above (the threshold set on the questionnaire corresponding to intermediate symptomatology). A second questionnaire created for the study detailed maternal history, pregnancy experience, and lifestyle.</p><p><strong>Results: </strong>A total of sixty-four women were included from September 20, 2022, to February 15, 2023. Eighteen women (28%) evaluated had anxious symptomatology and thirteen women (20%) had depressive symptomatology. Factors significantly associated with anxiety were poor pregnancy experience (P=0.04), the need for psychological follow-up during pregnancy (P<0.01), country of birth (P=0.022), as well as psychiatric history such as previous consultations with a mental health specialist (P=0.015) and previous psychotropic treatment (P=0.028). Additionally, a history of violence (respectively, P=0.034 and P<0.01) and the women's belief that a consultation with a psychologist would benefit them were also associated with anxious and depressive symptomatology (respectively, P<0.01 and P<0.01) CONCLUSION: Our results highlight the importance and necessity of enhancing the screening and prevention of various mental disorders during pregnancy. It would be interesting to implement organized screening for anxiety, similar to depression, in pregnant women hospitalized at home and for the entire obstetric population.</p>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}